Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

34
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
34
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

38
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
38
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

569
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
569
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

44
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
44
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

47
Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
47
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

43
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
43

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Subspecialization Alignment: How Residents Tailor Experiences Before Fellowship.

Urology practice·2026
Same author

A Review of Prostatitis-Reply.

JAMA·2025
Same author

Trends in Urology Resident Surgical Autonomy: What Do ACGME Chief Resident Case Logs Indicate?

Urology·2025
Same author

Interactions between heme and G-quadruplex DNA involve the oxygen of guanine.

Journal of inorganic biochemistry·2025
Same author

Impact of Subsequent Fellowship on Urology Chief Resident Case Log Volumes.

Journal of surgical education·2025
Same author

Preclinical characterization of MTX-101: a novel bispecific CD8 Treg modulator that restores CD8 Treg functions to suppress pathogenic T cells in autoimmune diseases.

Frontiers in immunology·2024
Same journal

Deescalation, Discontinuation, and Deimplementation Trials: Evaluating Whether and How to Do Less.

JAMA·2026
Same journal

Surgical and Endoscopic Therapies for GERD.

JAMA·2026
Same journal

The Psychedelic Therapies Executive Order: On Approval and Clinical Readiness.

JAMA·2026
Same journal

"Suturing": Love, Death, and Perfection's Limits.

JAMA·2026
Same journal

What Is Low Back Pain?

JAMA·2026
Same journal

From Silicon Valley to the Vatican-The Expanding Debate on AI Ethics.

JAMA·2026
See all related articles

Related Experiment Video

Updated: Sep 8, 2025

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation
09:49

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation

Published on: August 13, 2015

9.4K

Prostatitis: A Review.

Benjamin J Borgert1, Eric M Wallen2, Minh N Pham1

  • 1Department of Urology, University of North Carolina School of Medicine, Chapel Hill.

JAMA
|August 11, 2025
PubMed
Summary
This summary is machine-generated.

Prostatitis, affecting 9.3% of men, has distinct treatments for acute bacterial, chronic bacterial, and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Key treatments include antibiotics for bacterial forms and alpha-blockers for CP/CPPS urinary symptoms.

More Related Videos

Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis
06:46

Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis

Published on: January 16, 2013

16.0K
Transurethral Instillation Procedure in Adult Male Mouse
04:01

Transurethral Instillation Procedure in Adult Male Mouse

Published on: November 2, 2017

16.1K

Related Experiment Videos

Last Updated: Sep 8, 2025

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation
09:49

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation

Published on: August 13, 2015

9.4K
Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis
06:46

Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis

Published on: January 16, 2013

16.0K
Transurethral Instillation Procedure in Adult Male Mouse
04:01

Transurethral Instillation Procedure in Adult Male Mouse

Published on: November 2, 2017

16.1K

Area of Science:

  • Urology
  • Infectious Diseases
  • Pain Management

Background:

  • Prostatitis is a common condition affecting approximately 9.3% of men.
  • It encompasses acute bacterial prostatitis, chronic bacterial prostatitis, and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
  • Each subtype presents unique diagnostic and therapeutic challenges.

Purpose of the Study:

  • To outline the distinct diagnostic criteria and first-line treatment strategies for different types of prostatitis.
  • To highlight the efficacy of specific antibiotic classes and alpha-blockers in managing these conditions.

Main Methods:

  • Review of current medical literature and clinical guidelines for prostatitis diagnosis and management.
  • Analysis of treatment outcomes for acute bacterial prostatitis, chronic bacterial prostatitis, and CP/CPPS.
  • Comparison of therapeutic agents, including broad-spectrum antibiotics and alpha-blockers.

Main Results:

  • Acute bacterial prostatitis typically responds to broad-spectrum antibiotics (e.g., piperacillin-tazobactam, ceftriaxone, ciprofloxacin) with high success rates (92%-97%).
  • Chronic bacterial prostatitis requires longer antibiotic courses (≥4 weeks) of fluoroquinolones (e.g., levofloxacin, ciprofloxacin).
  • Alpha-blockers (e.g., tamsulosin, alfuzosin) are first-line therapy for CP/CPPS with urinary symptoms, showing significant improvement in the NIH-CPSI score.

Conclusions:

  • Effective management of prostatitis relies on accurate subtype diagnosis.
  • Tailored therapeutic approaches, including specific antibiotics and alpha-blockers, are crucial for successful outcomes.
  • Understanding these distinct treatment pathways improves patient care for prostatitis.